NEW YORK , Aug. 26, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA).
Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Walgreens and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until September 10, 2024 , to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired Walgreens securities during the Class Period. A copy of the Complaint can be obtained a t www.pomerantzlaw.
com . [Click here for information about joining the class action] On June 27, 2024 , Walgreens announced its financial results for the third quarter of fiscal year 2024 and reduced its revenue guidance for the fourth quarter and full fiscal year 2024. Among other items, Walgreens reported that "[a]djusted EPS was $0.
63 , down 36.6 percent on a constant currency basis compared to the year-ago quarter." The Company attributed its disappointing results and lowered guidance to "significant challenges in the U.
S. Retail Pharmacy business stemming from a worse-than-expected consumer environment and challenging .